高级检索
当前位置: 首页 > 详情页

Systematic comparation of the biological and transcriptomic landscapes of human amniotic mesenchymal stem cells under serum-containing and serum-free conditions

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Hematology, The First Affiliated Hospital of Kunming MedicalUniversity, Hematology Research Center of Yunnan Province, Kunming 650032,China [2]Department of Hematology, Yunnan Cancer Hospital, The ThirdAffiliated Hospital of Kunming Medical University, Yunnan Cancer Center,Kunming 650118, China [3]Department of Hematology, The Second Hospitalof Hebei Medical University, Shijiazhuang 050000, China [4]Key Laboratoryof Molecular Diagnostics and Precision Medicine for Surgical Oncologyin Gansu Province & NHC Key Laboratory of Diagnosis and Therapy of GastrointestinalTumor, Gansu Provincial Hospital, Lanzhou 730000, China [5]KeyLaboratory of Radiation Technology and Biophysics, Hefei Institute of PhysicalScience, Chinese Academy of Sciences, 350 Shushanhu Road, Shushan District,Hefei 230031, Anhui, China [6]Center for Cellular Therapies, The First AffiliatedHospital of Shandong First Medical University, Jinan 250014, China
出处:
ISSN:

关键词: Human amniotic mesenchymal stem cells (hAMSCs) Serum-containing Serum-free Biological signatures Transcriptomic characteristics

摘要:
Human amniotic mesenchymal stem cells (hAMSCs) are splendid cell sources for clinical application in the administration of numerous refractory and relapse diseases. Despite the preferable prospect of serum-free (SF) condition for cell product standardization and pathogenic contamination remission, yet the systematic and detailed impact upon hAMSCs at both cellular and transcriptomic levels is largely obscure.For the purpose, we preconditioned hAMSCs under serum-containing (SC) and SF medium for 48 h and compared the biological signatures and biofunctions from the view of cell morphology, immunophenotypes, multi-lineage differentiation in vitro, cell vitality, cytokine expression, and immunosuppressive effect upon the subpopulations of T lymphocytes, together with the PI3K-AKT-mTOR signaling reactivation upon cell vitality. Meanwhile, we took advantage of RNA-SEQ and bioinformatic analyses to verify the gene expression profiling and genetic variation spectrum in the indicated hAMSCs.Compared with those maintained in SC medium, hAMSCs pretreated in SF conditions manifested conservation in cell morphology, immunophenotypes, adipogenic differentiation, and immunosuppressive effect upon the proliferation and activation of most of the T cell subpopulations, but with evaluated cytokine expression (e.g., TGF-β1, IDO1, NOS2) and declined osteogenic differentiation and cell proliferation as well as proapoptotic and apoptotic cells. The declined proliferation in the SF group was efficiently rescued by PI3K-AKT-mTOR signaling reactivation. Notably, hAMSCs cultured in SF and SC conditions revealed similarities in gene expression profiling and variations in genetic mutation at the transcriptome level. Instead, based on the differentially expressed genes and variable shear event analyses, we found those genes were mainly involved in DNA synthesis-, protein metabolism-, and cell vitality-associated biological processes and signaling pathways (e.g., P53, KRAS, PI3K-Akt-mTOR).Collectively, our data revealed the multifaceted cellular and molecular properties of hAMSCs under SC and SF conditions, which suggested the feasibility of serum-free culture for the preferable preparation of standardized cell products for hAMSC drug development and clinical application.© 2022. The Author(s).

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 细胞与组织工程 2 区 细胞生物学 2 区 医学:研究与实验
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 细胞与组织工程 2 区 细胞生物学 2 区 医学:研究与实验
JCR分区:
出版当年[2022]版:
Q1 CELL & TISSUE ENGINEERING Q1 CELL BIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 CELL & TISSUE ENGINEERING Q1 CELL BIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Hematology, The First Affiliated Hospital of Kunming MedicalUniversity, Hematology Research Center of Yunnan Province, Kunming 650032,China [2]Department of Hematology, Yunnan Cancer Hospital, The ThirdAffiliated Hospital of Kunming Medical University, Yunnan Cancer Center,Kunming 650118, China
通讯作者:
通讯机构: [1]Department of Hematology, The First Affiliated Hospital of Kunming MedicalUniversity, Hematology Research Center of Yunnan Province, Kunming 650032,China [4]Key Laboratoryof Molecular Diagnostics and Precision Medicine for Surgical Oncologyin Gansu Province & NHC Key Laboratory of Diagnosis and Therapy of GastrointestinalTumor, Gansu Provincial Hospital, Lanzhou 730000, China [5]KeyLaboratory of Radiation Technology and Biophysics, Hefei Institute of PhysicalScience, Chinese Academy of Sciences, 350 Shushanhu Road, Shushan District,Hefei 230031, Anhui, China [6]Center for Cellular Therapies, The First AffiliatedHospital of Shandong First Medical University, Jinan 250014, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)